Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-047612)

Filing Details

Accession Number:: 0001209191-13-047612
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-10-07 15:23:16
Reporting Period:: 2013-03-12

Filing Date:: 2013-10-07
Accepted Time:: 2013-10-07 15:23:16
Original Submission Date:: 2013-03-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949858	Oncogenex Pharmaceuticals Inc.	OGXI	In Vitro & In Vivo Diagnostic Substances (2835)	954343413

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229762	Cindy Jacobs	1522 217Th Place Se, Suite 100 Bothell WA 98021	Evp, Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-12	534	$11.90	22,551	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amended Form 4 is filed to correct the transaction code, which was previously inadvertently reported as "F", and the sales price. The sales reported on this amended Form 4 were made for the sole purpose of covering the reporting person's tax liability in connection with the settlement of RSUs on March 12, 2013, which transaction was previously reported.